세계의 봉합 앵커 디바이스 시장(2023-2030년)

Global Suture Anchor Devices Market Size, Share & Trends Analysis Report by Material Type (Metallic Suture Anchor, Bio-Absorbable Suture Anchor, and Others), by Product (Absorbable, and Non-Absorbable), by Tying Type (Knotted Suture Anchors, and Knotless Suture Anchors), by End-Use (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2024-2031)

The global suture anchor devices market is anticipated to grow at a CAGR of 4.3% during the forecast period (2024-2031). Significant factors attributed to market growth includes increasing prevalence of orthopedic injuries, and growing use in procedures to address issues related to ligaments, and other musculoskeletal structures. For instance, iIn December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28.0% of all work-induced ill health.

Segmental Outlook

The global suture anchor devices market is segmented on the by material type, product, tying type, and end-use. Based on the material type, the market is sub-segmented into metallic suture anchor, bio-absorbable suture anchor, and others. Others include polyetheretherketone (PEEK) suture anchor devices. Based on the product, the market is sub-segmented into absorbable, and non-absorbable. Based on the tying type, the market is sub-segmented into knotted suture anchors, and knotless suture anchors. Further, based on end-use, the market is sub-segmented into hospitals, clinics, and ambulatory surgical centers. Among the material type, the bio-absorbable suture anchor sub-segment is anticipated to hold a considerable share of the market, owing to the reducing the risk of adverse reactions, inflammation, or rejection, making them suitable for a wide range of patients.

The Knotless Suture Anchors Sub-Segment is Anticipated to Hold a Considerable Share of the Global Suture Anchor Devices Market

Among the tying type, knotless suture anchors sub-segments expected to grow over the forecast period. The segment is driven by the growing trend towards minimally invasive procedures in orthopedic and soft tissue surgeries contributes to the demand for knotless suture anchor devices. Knotless suture anchors eliminate the need for tying knots during surgery, simplifying the procedure, and reducing the risk of complications, and are preferred by surgeons for their ease of use and potential for faster surgical times. Thus, the manufacturers are emphasizing on launching new products to cater to the demand in the market. In September 2020, Smith+Nephew plc, the medical technology business, launched the HEALICOIL™ KNOTLESS Suture Anchor, expanding its revolutionary line of advanced healing solutions for rotator cuff repair. This portfolio included the innovative REGENETEN™ Bioinductive Implant and novel REGENESORB™ Material. The open architecture design of the HEALICOIL KNOTLESS Suture Anchor coupled with REGENESORB Material was designed to facilitate a jump start in bone healing and formation.

Regional Outlook

The global suture anchor devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to grow over the forecast period, owing to the growing demand for suture anchor devices, increasing geriatric population, growing number of minimally invasive procedures, supportive government initiatives, and favorable healthcare policies, driving the suture anchor devices market in the Asia-Pacific.

The North America Region is Expected to Hold at a Significant CAGR in the Global Suture Anchor Devices Market

North America is expected to hold a prominent share in the suture anchor devices market, owing to the increasing prevalence of sports-related injuries and age-related orthopedic conditions. As reported in the Arthroscopy, Sports Medicine, and Rehabilitation journal, a study conducted in 2022 revealed that 21% of players experienced structural knee injuries, with an overall injury rate of 5.4 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.2/1,000 GE) followed by less than 30 years old (3.1/1,000 GE), 25 to 29 years (3.0/1,000 GE), and 20 to 24 years (2.3/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.9/1,000 GE), followed by 20.0 to 29.9 minutes (3.0/1,000 GE), and 10.0 to 19.9 minutes (1.8/1,000 GE). Thus, an increasing geriatric population is associated with an increase in orthopedic surgeries, thus boosting the market studied in the region. In April 2022, Statistics Canada published the article "A portrait of Canada's growing population aged 85 and older from the 2021 Census", that there were 7.3 million people aged 65 and older in the country. Furthermore, over the next 25 years (by 2046), the population aged 85 and above may get triple to almost 2.5 million people.

Market Players Outlook

The major companies serving the suture anchor devices market include Arthrex, Inc., ConMed Corp., Johnson and Johnson (DePuy Synthes, Inc.), Smith & Nephew plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, Stryker Corp., launched the Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system used Citregen™, a bioresorbable material designed to mimic the chemistry and structure of native bone.

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global suture anchor devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Arthrex, Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. ConMed Corp.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Johnson and Johnson (DePuy Synthes, Inc.)
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Smith & Nephew plc
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Suture Anchor Devices Market by Material Type
  • 4.1.1. Metallic Suture Anchor
  • 4.1.2. Bio-Absorbable Suture Anchor
  • 4.1.3. Others (PEEK Suture Anchor Devices)
• 4.2. Global Suture Anchor Devices Market by Product
  • 4.2.1. Absorbable
  • 4.2.2. Non-Absorbable
• 4.3. Global Suture Anchor Devices Market by Tying Type
  • 4.3.1. Knotted Suture Anchors
  • 4.3.2. Knotless Suture Anchors
• 4.4. Global Suture Anchor Devices Market by End-Use
  • 4.4.1. Hospitals
  • 4.4.2. Clinics
  • 4.4.3. Ambulatory Surgical Centers

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Anika Therapeutics Inc.
• 6.2. Enovis
• 6.3. In2Bones
• 6.4. MedShape Inc.,
• 6.5. Medtronic plc.,
• 6.6. Orthomed
• 6.7. Ossio Inc.
• 6.8. Paragon 28, Inc
• 6.9. Parcus Medical, LLC.
• 6.10. Stryker Corp.,
• 6.11. Teknimed
• 6.12. Tulpar Medical Solutions
• 6.13. VIMS
• 6.14. Wright Medical Group N.V.
• 6.15. Zimmer Biomet Holdings, Inc.